Creatine and Cognition: What the Evidence Supports, and What It Doesn't

What creatine actually does in the brain

Creatine is not a stimulant and it is not a treatment for brain fog. It is a substrate in an energy-buffering system, and the honest summary is narrower than most of what gets written: creatine produces measurable cognitive effects in specific stressed states, most consistently acute sleep deprivation and low dietary intake, and small or absent effects in rested, well-fed adults. Whether it helps your fog depends on why your thinking slowed.

One disclosure first, because it should change how you read this page. Numin's formula contains no creatine, and Numin does not sell creatine in any form. Nothing here helps a product line, so the assessment can be what the literature supports, not what a label needs.

Creatine's role is straightforward biochemistry. Cells hold most of their creatine as phosphocreatine, a high-energy phosphate store that regenerates ATP from ADP through the creatine kinase reaction. ATP is what neurons spend on restoring ion gradients after firing and on running the transporters that keep the synaptic space clear, and that demand spikes. Phosphocreatine covers those spikes within seconds, before slower pathways catch up. It is less a fuel tank than a shock absorber.

The brain both synthesises creatine locally and imports it across the blood-brain barrier through a dedicated transporter. The clearest evidence that this matters comes from the clinic: inherited defects in creatine synthesis or transport present with intellectual disability and seizures, and oral creatine improves outcomes in the synthesis disorders. That establishes creatine as necessary for normal brain function, not that additional creatine improves an already normal brain, and conflating the two is the most common error in this discussion. Supply caps it further: loading raises muscle creatine by roughly a fifth, while magnetic resonance spectroscopy shows brain creatine rising far less, so a supplement that barely moves its target tissue should produce small effects.

Where the evidence is strongest: sleep deprivation

A pattern runs through the creatine and cognition literature that headlines tend to miss. Creatine's cognitive effects appear most reliably when the brain's energy system is under acute strain, and fade toward nothing when it is not. Sleep deprivation is the clearest example.

Mid-2000s trials in Psychopharmacology tested creatine against the cognitive and psychomotor decline that follows a night without sleep, and reported supplemented participants holding performance better than controls on some measures. More recently, a 2024 study in Scientific Reports gave a single large dose - many times the usual maintenance amount - during overnight sleep deprivation, and reported improvements in processing speed alongside measurable shifts in brain high-energy phosphates on magnetic resonance spectroscopy.

Mechanistically this fits. Sleep loss disturbs brain energy handling, and a system already struggling to keep ATP available benefits more from a larger phosphate buffer than one with slack in it.

"A supplement tested against a night without sleep has not been tested against your Tuesday at 3pm."

Sleep loss degrades nearly everything measurable about cognition, and energy availability is only one mechanism involved. If you are chronically short of sleep, creatine is not the best-evidenced intervention - the sleep is, and the cost of late nights to decision quality stands on its own. If your fog has a cause the creatine studies never touched, such as thyroid disease or iron deficiency, no supplement resolves it; the plausible causes of brain fog are worth working through first.

Effect sizes: modest, domain-specific, heterogeneous

Where creatine does produce cognitive effects in healthy people, they are small to moderate and unevenly distributed. Memory tasks show the most consistent signal, reasoning and intelligence measures show something in some trials, and attention, reaction time and processing speed are inconsistent. Anyone quoting one headline percentage for creatine and cognition is quoting a number the literature does not contain.

The meta-analytic picture is mixed, and the reviews say so themselves. A systematic review published in Experimental Gerontology in 2018 examined randomised trials in healthy people and located the most defensible signal in short-term memory and reasoning, with thinner evidence elsewhere. Later meta-analyses focused on memory report small positive pooled effects, with older adults appearing to respond more than young adults. Heterogeneity is high throughout - different doses, durations, populations and test batteries.

There are also null results, and they are not marginal. Randomised trials in young, healthy, well-fed adults have measured cognition after weeks of supplementation and found nothing distinguishable from placebo - the expected outcome if creatine relieves a constraint the population tested does not have. Our checklist for evaluating cognitive performance aids sets out what to look for before you believe a label.

The alternative failure mode is measurable and it is not an energy shortage. A widely cited analysis of parole rulings by Danziger and colleagues found the proportion of favourable decisions fell steadily across a judicial session and recovered after breaks. Those judges were awake, fed and expert, and their judgment still decayed with accumulated decisions. That curve is what most professionals describe as afternoon fog, and it is not the curve creatine has been tested against.

Who plausibly benefits most

Two groups have the strongest case, and both follow from one principle: creatine helps most where baseline stores are lowest or acute demand is highest.

People with low dietary intake come first. Creatine in food comes almost entirely from meat and fish, so vegetarians and vegans carry measurably lower stores than omnivores. A double-blind crossover trial by Rae and colleagues, published in Proceedings of the Royal Society B in 2003, supplemented vegetarians and reported improvements on working memory and processing tasks. Later work found benefit concentrated in vegetarians rather than omnivores, the group with room to move.

The sleep-deprived come second - not the mildly tired, but people working through genuine sleep restriction: night-shift clinicians, on-call staff, new parents. Older adults may be a third group.

Dosing, loading and the honest trade-offs

Two protocols reach the same place. Loading takes roughly 20 grams a day in four split doses for five to seven days, then 3 to 5 grams daily to hold saturation; skipping the load and taking 3 to 5 grams daily reaches the same levels in about three to four weeks. Creatine monohydrate is the form with the research behind it; the pricier variants have not earned their premium.

Loading draws water into muscle cells, so most people gain a kilogram or two in the first week - intracellular water rather than fat, but it shows on a scale. Large single doses cause gastrointestinal discomfort in a meaningful minority, which splitting the dose usually resolves.

Long-term creatine use has an unusually good record in healthy adults across decades of trials. Creatine does raise serum creatinine, the marker clinicians use to estimate kidney function; the rise reflects the supplement rather than kidney damage, but it can confuse a lab result. If you have kidney disease, take medication affecting renal function, or have blood work scheduled, speak to your doctor first and tell them you are taking it. This page reviews evidence; it is not medical advice.

Where creatine stops, and what a different mechanism addresses

Creatine answers one question: whether enough rapidly available phosphate exists to keep ATP regenerating when demand spikes. Supply is not the only way a decision-making system degrades. Creatine has been studied in preclinical models of glutamate excitotoxicity, but protecting cells from an insult in a model is not the same as accelerating clearance in a working brain.

Every decision fires glutamate, the brain's principal excitatory neurotransmitter, in the lateral prefrontal cortex. Glutamate must be cleared from the synaptic space between signals. Under sustained decision-making it accumulates faster than the system clears it, and neural signalling becomes less efficient. That is a clearance problem rather than a fuel problem, and it produces the pattern most professionals recognise after lunch. Adding capacity to the phosphate buffer does not address a clearance bottleneck.

That clearance pathway is what Numin was formulated to support, and the reason to raise it here is that it targets the mechanism creatine does not. Numin is a stimulant-free powdered drink with five named ingredients rather than a proprietary blend. In a randomised, placebo-controlled crossover trial published in Frontiers in Nutrition in 2025, 23 healthy adults completed two 13-hour sessions of sustained cognitive load with a seven-day washout between arms. The placebo arm declined significantly in cognitive efficiency after about four hours; the Numin arm held baseline performance to the end and made 43% fewer decision errors, with zero adverse events. The limits deserve stating as plainly as the result: 23 participants, a single trial, a competitive-play population, one 13-hour window - a promising study, not a settled literature. The mechanism and each ingredient's job are set out on the Numin science page, and the formula is sold as a 20-serving pack.

Creatine and glutamate clearance answer different questions, and the mistake is expecting either to solve the problem the other was built for.

Cognitive supplements are usually sold on a general promise - clearer thinking, better focus - which lets a modest, domain-specific effect stand in for a broad one. Name the mechanism, identify the state it applies to, then check whether you are in that state.